A Feasibility Study of Wearable Device in Assessing Respiratory Condition Change of Patients With Exacerbation of COPD

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2023

Conditions
COPD Exacerbation
Interventions
DEVICE

SenseGuard

"SG is a wireless, wearable medical device, which includes nano-based sensors. It can seamlessly measure patient's tidal breathing during daily activities. SG extracts series of critical respiratory parameters, including; Respiration Rate (RR), Inhalation and Exhalation duration and ratio (I/E), as well as novel biomarkers. SG parameters are applicable to evaluate COPD patients' condition, or for monitoring patients with other respiratory conditions.~SG components are:~RSM (Respiratory Sensing Module): non-invasive module with sensors that can detect the exhaled humidity and condensation. The RSM is a non-sterile, disposable, single patient use.~ECU (Electronic Control Unit): a re-usable, wireless data acquisition and transmission unit. The ECU is connected to the RSM during the measurement and transmits the data via Bluetooth to the SG software.~SenseGuard™ Software: for data management, acquisition, processing, logging and presentation of the digital respiratory signals."

Trial Locations (2)

Unknown

Universitätsklinikum Halle (Saale) Universitätsklinik und Poliklinik für Innere Medizin I, Halle

Galilee Medical Center, Nahariya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NanoVation

INDUSTRY

NCT05153122 - A Feasibility Study of Wearable Device in Assessing Respiratory Condition Change of Patients With Exacerbation of COPD | Biotech Hunter | Biotech Hunter